SLN Silence Therapeutics plc

Fundamentals / CIK 0001479615 / USD
Other share classes on CIK 0001479615: SLNCF

Silence Therapeutics plc reported $456K in revenue and a net loss of $51.42M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a 95.0% gross margin and a -12343.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SLN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$51.99M$26.00M$0-$86.53MFY 2022 Revenue: $21.66MFY 2022 Net Income: -$50.33M2022FY 2023 Revenue: $31.64MFY 2023 Net Income: -$54.23M2023FY 2024 Revenue: $43.26MFY 2024 Net Income: -$45.31M2024FY 2025 Revenue: $559KFY 2025 Net Income: -$88.61M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue $559K $43.26M $31.64M $21.66M
Cost of Revenue $215K $11.81M $12.87M $13.46M
Gross Profit $344K $31.45M $18.78M $8.19M
Research & Development $67.75M $67.88M $56.94M $43.55M
Operating Income -$91.08M -$63.32M -$64.38M -$61.04M
EBITDA -$90.52M -$62.73M -$63.76M -$60.44M
Income Before Tax -$88.60M -$44.46M -$53.27M -$49.65M
Income Tax Expense $11K $845K $956K $688K
Net Income -$88.61M -$45.31M -$54.23M -$50.33M
Basic EPS -$0.63 -$0.33 -$0.49 -$0.52
Diluted EPS -$0.63 -$0.33 -$0.49 -$0.52
Basic Shares Outstanding 141.7M 138.8M 111.3M 96.6M
Diluted Shares Outstanding 141.7M 138.8M 111.3M 96.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $422K $34K $159K $224K $142K $25.30M
Cost of Revenue $0 $0 $11K $12K $64K $85K $54K $2.04M
Gross Profit $0 $0 $411K $22K $95K $139K $88K $23.27M
Research & Development $9.30M $9.15M $9.12M $8.75M $20.54M $17.65M $20.81M $22.08M
Operating Income -$14.22M -$13.87M -$15.74M -$12.46M -$26.24M -$23.96M -$28.41M -$4.35M
EBITDA -$14.12M -$13.76M -$15.63M -$12.35M -$26.09M -$23.82M -$28.27M -$4.21M
Income Before Tax -$12.43M -$12.27M -$14.96M -$11.77M -$20.96M -$27.34M -$28.53M $12.63M
Income Tax Expense $0 $1.0K $0 $0 $1.0K $10K $0 $324K
Net Income -$12.43M -$12.27M -$14.96M -$11.77M -$20.96M -$27.35M -$28.53M $12.30M
Basic EPS -$0.08 -$0.09 -$0.11 -- -$0.15 -$0.19 -$0.20 --
Diluted EPS -$0.08 -$0.09 -$0.11 -- -$0.15 -$0.19 -$0.20 --
Basic Shares Outstanding 165.6M 141.7M 141.7M -- 141.7M 141.7M 141.7M --
Diluted Shares Outstanding 165.6M 141.7M 141.7M -- 141.7M 141.7M 141.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $11.28M $121.3M $68.79M
Short-Term Investments $73.84M $26.00M --
Cash & Short-Term Investments $85.10M $147.3M $68.79M
Accounts Receivable, Net $0 $972K $290K
Other Current Assets $11.54M $14.66M $11.63M
Total Current Assets $118.7M $187.4M $103.2M
Property, Plant & Equipment, Net $1.58M $1.82M $1.94M
Goodwill $10.62M $9.39M $9.98M
Intangible Assets $288K $312K --
Other Non-Current Assets $127K $3.59M $3.65M
Total Non-Current Assets $12.78M $15.27M $16.30M
Total Assets $131.4M $202.6M $119.4M
Accounts Payable $4.41M $3.70M $3.35M
Deferred Revenue (Current) $168K $306K $6.57M
Total Current Liabilities $13.61M $16.82M $22.34M
Deferred Revenue (Non-Current) $55.45M $51.79M $75.00M
Total Non-Current Liabilities $55.52M $51.79M $75.12M
Total Liabilities $69.14M $68.61M $97.45M
Total Debt (incl. Leases) $160K $117K $346K
Common Stock $10.29M $10.29M $8.85M
Retained Earnings -$562.6M -$474.0M -$431.9M
Accumulated Other Comp. Income -$2.98M -$11.78M -$10.72M
Total Stockholders' Equity $62.30M $134.0M $21.99M
Total Equity $62.30M $134.0M $21.99M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $247.7M $72.05M $5.66M $11.28M $82.03M $41.74M $64.89M $121.3M
Short-Term Investments $0 $0 $64.42M $73.84M $20.16M $72.42M $71.65M $26.00M
Cash & Short-Term Investments $247.7M $72.10M $70.10M $85.10M $102.2M $114.2M $136.5M $147.3M
Accounts Receivable, Net -- -- $0 $0 $28K $85K $41K $972K
Other Current Assets $11.94M $12.94M $10.56M $11.54M $9.26M $14.36M $16.42M $14.66M
Total Current Assets $269.6M $94.28M $102.9M $118.7M $133.6M $148.6M $169.8M $187.4M
Property, Plant & Equipment, Net $1.22M $1.32M $1.40M $1.58M $1.66M $1.77M $1.69M $1.82M
Goodwill $10.25M $10.32M $10.36M $10.62M $10.62M $10.62M $10.62M $9.39M
Intangible Assets -- -- -- $288K -- -- -- $312K
Other Non-Current Assets $127K $127K $127K $127K $399K $3.91M $3.61M $3.59M
Total Non-Current Assets $11.92M $12.13M $12.27M $12.78M $13.16M $16.68M $15.51M $15.27M
Total Assets $281.5M $106.4M $115.1M $131.4M $146.8M $165.2M $185.3M $202.6M
Accounts Payable -- -- -- $4.41M -- -- -- $3.70M
Deferred Revenue (Current) $0 $0 $0 $168K $301K $457K $392K $306K
Total Current Liabilities $11.26M $12.71M $10.46M $13.61M $17.38M $14.77M $19.26M $16.82M
Deferred Revenue (Non-Current) $55.22M $55.22M $55.22M $55.45M $55.25M $56.31M $53.29M $51.79M
Total Non-Current Liabilities $55.22M $55.23M $55.26M $55.52M $55.35M $56.31M $53.29M $51.79M
Total Liabilities $66.48M $67.94M $65.72M $69.14M $72.73M $71.08M $72.56M $68.61M
Total Debt (incl. Leases) $87K $112K $136K $160K $182K -- $60K $117K
Common Stock $13.33M $10.29M $10.29M $10.29M $10.29M $10.29M $10.29M $10.29M
Retained Earnings -$601.9M -$589.6M -$577.5M -$562.6M -$550.8M -$529.8M -$502.5M -$474.0M
Accumulated Other Comp. Income -$3.48M -$3.34M -$3.37M -$2.98M -$3.07M -$1.40M -$8.08M -$11.78M
Total Stockholders' Equity $215.0M $38.47M $49.40M $62.30M $74.06M $94.16M $112.7M $134.0M
Total Equity $215.0M $38.47M $49.40M $62.30M $74.06M $94.16M $112.7M $134.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$88.61M -$45.31M -$54.23M -$50.33M
Depreciation & Amortization $555K $593K $621K $596K
Stock-Based Compensation $8.07M $16.31M $16.27M $12.69M
Change in Receivables $1.02M -$904K $392K -$723K
Operating Cash Flow -$62.27M -$67.64M -$49.46M -$57.04M
Capital Expenditure -$55K -$211K -$56K -$173K
Free Cash Flow -$62.33M -$67.85M -$49.52M -$57.22M
Investing Cash Flow -$47.99M -$21.97M $19.29M -$20.50M
Common Stock Issued $15K $142.1M $31.94M $52.58M
Financing Cash Flow $15K $142.1M $31.94M $52.58M
Net Change in Cash -$110.2M $52.48M $1.77M -$24.96M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$12.43M -$12.27M -$14.96M -$11.77M -$20.96M -$27.35M -$28.53M $12.30M
Depreciation & Amortization $106K $108K $106K $113K $156K $148K $138K $140K
Stock-Based Compensation $777K $1.31M $2.45M -$86K $2.54M $2.08M $3.54M $3.98M
Change in Receivables $0 $0 $0 $30K $62K -$8.0K $940K -$611K
Operating Cash Flow -$12.78M $1.52M -$15.60M -$17.29M -$10.89M -$21.78M -$12.31M -$27.48M
Capital Expenditure $0 $0 $0 $0 -$3.0K -$48K -$4.0K -$62K
Free Cash Flow -$12.78M $1.52M -$15.60M -$17.29M -$10.89M -$21.83M -$12.31M -$27.54M
Investing Cash Flow $0 $64.94M $10.00M -$53.34M $51.29M -$1.56M -$44.38M $66.12M
Common Stock Issued $188.3M $2.0K $0 $0 $0 $1.0K $14K -$98K
Financing Cash Flow $188.3M $2.0K $0 $0 $0 $1.0K $14K -$98K
Net Change in Cash $175.6M $66.46M -$5.60M -$70.62M $40.40M -$23.34M -$56.68M $38.55M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 61.5% 72.7% 59.3% 37.8%
Operating Margin -16292.8% -146.4% -203.5% -281.9%
Net Profit Margin -15851.9% -104.7% -171.4% -232.4%
Return on Equity (ROE) -142.2% -33.8% -246.6% --
Return on Assets (ROA) -67.4% -22.4% -45.4% --
Current Ratio 8.72x 11.14x 4.62x --
Quick Ratio 6.25x 8.81x 3.09x --
Debt to Equity 0.00x 0.00x 0.02x --
Revenue Growth (YoY) -98.7% +36.7% +46.1% --
Gross Profit Growth (YoY) -98.9% +67.5% +129.2% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 95.0% 85.9% 79.5% 61.5% 91.3% 78.6% 67.3% 72.7%
Operating Margin -12343.6% -11106.8% -9345.1% -16292.8% -321.2% -319.2% -311.0% -146.4%
Net Profit Margin -11276.5% -9748.5% -8943.9% -15851.9% -249.9% -291.2% -258.2% -104.7%
Return on Equity (ROE) -23.9% -155.8% -151.9% -142.2% -87.1% -84.0% -63.4% -33.8%
Return on Assets (ROA) -18.3% -56.3% -65.2% -67.4% -44.0% -47.9% -38.6% -22.4%
Current Ratio 23.94x 7.42x 9.83x 8.72x 7.69x 10.06x 8.81x 11.14x
Quick Ratio 22.00x 5.67x 6.70x 6.25x 5.88x 7.74x 7.09x 8.81x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x -- 0.00x 0.00x
Revenue Growth (YoY) -100.0% -100.0% +197.2% -99.9% -89.4% -70.4% -99.1% --
Gross Profit Growth (YoY) -100.0% -100.0% +367.0% -99.9% -- -- -99.3% --
Net Income Growth (YoY) -- -- -- -195.7% -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001479615) · from December 31, 2022 Data through September 30, 2026 · synced Nov 20, 2026, 05:31 UTC · Open in terminal